Alosetron Pregnancy and Breastfeeding Warnings
Brand names: Lotronex
Medically reviewed by Drugs.com. Last updated on Mar 25, 2024.
Alosetron Pregnancy Warnings
This drug should be used during pregnancy only if clearly needed.
US FDA pregnancy category: B
Animal models have failed to reveal evidence of impaired fertility and fetal harm at doses up to 40 mg/kg/day. There are no adequate and well-controlled studies in pregnancy.
US FDA pregnancy category B: Animal reproduction studies have failed to demonstrate a risk to the fetus and there are no adequate and well-controlled studies in pregnant women.
Alosetron Breastfeeding Warnings
Caution is recommended.
Excreted into human milk: Unknown
Excreted into animal milk: Yes
Comment: The effects in the nursing infant are unknown.
See also
References for pregnancy information
- (2001) "Product Information. Lotronex (alosetron)." Glaxo Wellcome
References for breastfeeding information
- (2001) "Product Information. Lotronex (alosetron)." Glaxo Wellcome
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.